Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2023-09-11 00:00:00 ET · period of report 2023-09-07 · accession 0000895345-23-000530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-11 | 2023-09-07 | CLOV | Reynoso Jamie L. | CEO of Medicare Advantage | F - Tax | $1.31 | -53.0K | 1.98M | -3% | -$69.4K | |
| 2023-09-11 | 2023-09-07 | CLOV | Reynoso Jamie L. | CEO of Medicare Advantage | A - Grant | $0.00 | +652.5K | 2.03M | +47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-09-07 | F | D | 52,967 | $1.31 | 1,980,370 | D | — | — | (F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above. |
| 2 | Common | Class A Common Stock | 2023-09-07 | A | A | 652,452 | $0.00 | 2,033,337 | D | — | — | (F1) Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested and was settled on September 7, 2023, and 1/3 of the number of earned restricted stock units will vest on each of June 30, 2024 and June 30, 2025, subject to the reporting person's continued employment through each vesting date. |